Although still a matter of controversy [4], a number of delicate in vitro studies suggest that depletion of calstabin, which normally stabilizes the RyR2 channel complex, is related to CPVT pathogenesis [3,5,6]. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.